L

Longitude Capital

43 employees

Longitude Capital is a venture capital firm that invests in biotechnology and medical technology companies.

Investor insights

Sectors invested in

Health Care73
Biotechnology68
Medical36
Pharmaceutical30
Therapeutics27
Medical Device25
Health Diagnostics16
Biopharma13
Manufacturing11
Life Science7
Genetics6
Hospital6
Wellness5
Rapid Environmental Monitoring4
Quality Control Automation4
Quality Control Microbiology4
Rapid automated detection and enumeration4
Rapid Water and Bioburden Testing4
Eyewear4
Financial Services4

Funding rounds participated in

$1.5M sweet spot round size

Most of their 109 investments are in rounds between $30M and $73M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Angel Investment
Biotechnology
Financial Services
Finance
Venture Capital

Date founded

2006

Investments made

C

CG Oncology raised $105M on August 2, 2023

Investors: Decheng Capital, Avidity Partners, TCG X, Foresite Capital, RA Capital Management, L.P., Malin Corporation plc and Longitude Capital

C

CG Oncology raised $105M on August 2, 2023

Investors: Decheng Capital, Foresite Capital, Malin Corporation plc, TCG X, Avidity Partners, RA Capital Management, L.P. and Longitude Capital

Q

Quanta Therapeutics raised $51M on May 22, 2023

Investors: Sofinnova Ventures, Russia technology fund, Avidity Partners, Vida Ventures, LLC, Surveyor Capital and Longitude Capital

C

Cortica raised $75M on April 17, 2023

Investors: Questa Capital Management, ECHO, Ajax Health, Optum Ventures, Aperture Venture Partners, .406 Ventures, RA Capital Management, L.P., Autism Impact Fund and Longitude Capital

N

NOCD raised $34M on January 31, 2023

Investors: Cigna Ventures, Health Enterprise Partners, 7wire Ventures, F-Prime Capital Partners and Longitude Capital

A

Alpha-9 Theranostics Inc. raised $75M on December 14, 2022

Investors: Nextech Invest, Samsara BioCapital, Quark Venture and Longitude Capital

O

Opna Bio raised $38M on November 21, 2022

Investors: Northpond Ventures, Menlo Ventures and Longitude Capital

C

CG Oncology raised $120M on November 15, 2022

Investors: RA Capital Management, L.P., Acorn Bioventures, ORI Capital Limited, Sirona Capital, Decheng Capital and Longitude Capital

Z

Zenas BioPharma raised $118M on November 7, 2022

Investors: Tellus BioVentures, -, Xencor, Vivo Capital, Quan Capital 泉创资本, Perceptive Advisors, Wellington Management and Longitude Capital

R

Rivus Pharmaceuticals raised $132M on September 22, 2022

Investors: RA Capital Management, L.P., Medicxi and Longitude Capital

FAQ